James Kihara, Principal Accounting Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 359 shares at $23.80 ($9K) on 2022-02-23, disclosed to the SEC on 2022-02-25.
Open-market sale of $9k ACAD by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |